Infrasound phonophoresis with peptide bioregulators and amino acids in children with epilepsy in partial optic atrophy

Background. Approximately half of young children with seizures and increased convulsive readiness have postchiasmal visual disturbances. Congenital optic nerve atrophy is considered the most significant cause of blindness and visual impairment in children, especially premature infants. The diagnosis of epilepsy complicates the standard approach to the treatment of children with partial optic nerve atrophy. The choice of medical and physiotherapy treatment is limited. Therefore, we faced the question of the need to select modern gentle effective methods of complex treatment of patients in this group. To date, the methods of treatment of optic atrophy are aimed at improving blood circulation and metabolism of the retina and optic nerve, as well as at creating conditions that promote better conduction of neuronal excitation along the optic nerve fibers. The article describes the use of infrasonic phonophoresis with a complex of water-soluble polypeptide fractions of bovine retina, which has a stimulating effect on photoreceptors and cellular elements of the retina, improves functional interaction of pigment epithelium and outer segments of photoreceptors, glial cells in case of dystrophic changes, accelerates restoration of light sensitivity of the retina. The absence of complications and sufficiently high efficiency with more successful motor rehabilitation, improvement of intellectual abilities allow us to recommend this method of treatment to patients with epilepsy and partial atrophy of the optic nerve.

Conclusion. A non-invasive complex treatment method using infrasound phonophoresis, pneumomassage using peptide bioregulators and amino acids has a significant effect, but does not cause psychological trauma to children, which makes it possible to use the proposed therapy as a method of choice in pediatric patients with descending partial optic nerve atrophy against the background of epilepsy and with a high risk of developing convulsive activity.

1. Libman E. S. Disability due to pathology of the visual organ / In Ophthalmology. National manual. Moscow: GEOTAR-Media, 2006. P. 18-26. (In Russ.)

2. Neroev V. V. Selected lectures on pediatric ophthalmology. Moscow: GEOTAR-Media, 2009. P. 4-8. (In Russ.)

3. Libman E. S., Shakhova E. V. Blindness and disability due to pathology of the visual organ in Russia. Vestnik Ophthalmologii. 2006; 1: 35-37. (In Russ.)

4. Libman E. S. Modern positions of clinical and social ophthalmology. Vestnik Ophthalmologii. 2004; 1 (120): 10-12. (In Russ.)

5. Pyatyshina O. V., Sorokin E. L. Structure of disabling congenital pathology of the visual organ in children in Khabarovsk Krai. Fedorovskie chtenija: Mater. nauch.-prakt. konf. M., 2009. P. 64-65. (In Russ.)

6. Savina L.B., Pyatyshina O.V., Sorokin E. L., Zhazybaev R.S. Analysis of the nosological structure of the causes of blindness and low vision in children of a specialized boarding school. Sovremennye tehnologii v oftal'mologii No. 2. М., 2018. (In Russ.)

7. Khavronina K. V., Bogomolova A. A., Gorbunov A. V. Significance of variants of the structure of the arterial channel of the human brain at ischemic stroke. Ak. zhur. Zapadnoj Sibiri. 2014; 1: 10. (In Russ.)

8. Bragina L. K. Collateral blood circulation through the ocular artery in occlusion of the internal carotid artery (angiographic and neuroophthalmologic comparisons). Zhurnal nevropatol. i psihiatrii im. S. S. Korsakova. 1974. P. 961-965. (In Russ.)

9. Medvedev M. I., Zavadenko N. N., Petrukhin A. S., Troitskaya L. A., Ilyina E. S., et al. Disturbances of neuropsychic development in epilepsy in children and possibilities of their correction. Vestnik prakticheskoj nevrologii.1998; 4: 117-120. (In Russ.)

10. Epileptology of pediatric age / Edited by Prof. Petrukhin A. S. M.: Medicina, 2000. 624 P. (In Russ.)

11. Wolf N. l., Smeitink J. A. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology, 2002; 59: 1402-1405.

12. Zykov V. P., Mosin I. M., Safronov D. L., Iziumova E. B. Diagnostics of cerebral visual disturbances in patients with epilepsy of early age. (In Russ.)

13. Guseva M. R. Neuropeptide therapy in optic nerve atrophy in children. Mezhdunarodnyj nevrologicheskij zhurnal. 2011; 3: 85-89. (In Russ.)

14. Lobanova I. V. Complex two-stage treatment of optic nerve atrophy of different genesis in children: Synopsis of thesis prepared by candidate of Medical Sciences. М., 1997. 24 P. (In Russ.)

15. Gromova O. A. Neuroimmunomodulatory properties of cerebrolysin. In the book of abstracts: International Symposium "Cerebrolysin: pharmacological effects and place in clinical practice". М. 2002. P. 4-10. (In Russ.)

16. Windisch M. Cerebrolysin – recent results in the evaluation of multimodal action of the drug. In book: 3rd International Symposium on Cerebrolysin. М., 1991. (In Russ.)

17. Sukhanova I. V., Sidorenko E. E., Prityko A. G., Osipova K. V., Molodychenko E. S., Sukhanova A. A., Miguel D. V. Complex method of treatment of descending partial atrophy of the optic nerve in children with epilepsy. X Congress of Ophthalmologists of Russia. Collection of scientific materials. М., 2015. (In Russ.)

18. Shatokhina I. A., Baranov V. I., Bereznikov A. I., Pikalova E. S. Experience of treatment of partial optic nerve atrophy of vascular genesis. Actual problems of ophthalmology 2014. Moscow. (In Russ.)